“How does a global pharmaceutical giant modernize its internal treasury, employee benefits, and supplier payment infrastructure to match its scale across 140+ countries?”
Eli Lilly is one of the world's largest pharmaceutical companies, engaged in discovery, development, manufacture, and sale of pharmaceutical products. Its embedded finance footprint is primarily internal — focused on employee benefits (401(k) plans), global treasury and FX management, and supplier payments infrastructure. The company is not an embedded finance provider; rather it is a large enterprise consumer of financial services infrastructure.